Characterization and Evaluation of a Modified Local Lymph Node Assay Using ATP Content As a Non-radio Isotopic Endpoint
Overview
Toxicology
Affiliations
Introduction: The murine local lymph node assay (LLNA) is an accepted and widely used method for assessing the skin-sensitizing potential of chemicals. Here, we describe a non-radio isotopic modified LLNA in which adenosine triphosphate (ATP) content is used as an endpoint instead of radioisotope (RI); the method is termed LLNA modified by Daicel based on ATP content (LLNA-DA).
Methods: Groups of female CBA/JNCrlj mice were treated topically on the dorsum of both ears with test chemicals or a vehicle control on days 1, 2, and 3; an additional fourth application was conducted on day 7. Pretreatment with 1% sodium lauryl sulfate solution was performed 1 h before each application. On day 8, the amount of ATP in the draining auricular lymph nodes was measured as an alternative endpoint by the luciferin-luciferase assay in terms of bioluminescence (relative light units, RLU). A stimulation index (SI) relative to the concurrent vehicle control was derived based on the RLU value, and an SI of 3 was set as the cut-off value.
Results: Using the LLNA-DA method, 31 chemicals were tested and the results were compared with those of other test methods. The accuracy of LLNA-DA vs LLNA, guinea pig tests, and human tests was 93% (28/30), 80% (20/25), and 79% (15/19), respectively. The estimated concentration (EC) 3 value was calculated and compared with that of the original LLNA. It was found that the EC3 values obtained by LLNA-DA were almost equal to those obtained by the original LLNA.
Discussion: The SI value based on ATP content is similar to that of the original LLNA as a result of the modifications in the chemical treatment procedure, which contribute to improving the SI value. It is concluded that LLNA-DA is a promising non-RI alternative method for evaluating the skin-sensitizing potential of chemicals.
Li Y, Keller A, Cryan M, Ross A ACS Meas Sci Au. 2022; 2(2):96-105.
PMID: 35479102 PMC: 9026253. DOI: 10.1021/acsmeasuresciau.1c00026.
The LLNA: A Brief Review of Recent Advances and Limitations.
Anderson S, Siegel P, Meade B J Allergy (Cairo). 2011; 2011:424203.
PMID: 21747867 PMC: 3124934. DOI: 10.1155/2011/424203.